Defence Therapeutics OTC Stock Forecast - Simple Moving Average
| DTCFF Stock | USD 0.50 0.02 3.85% |
The Simple Moving Average forecasted value of Defence Therapeutics on the next trading day is expected to be 0.50 with a mean absolute deviation of 0.02 and the sum of the absolute errors of 1.17. Defence OTC Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Defence Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 10th of January 2026 the value of rsi of Defence Therapeutics' share price is below 20 suggesting that the otc stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
It is a matter of debate whether otc price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Defence Therapeutics based on different types of headlines from major news networks to social media. Using Defence Therapeutics hype-based prediction, you can estimate the value of Defence Therapeutics from the perspective of Defence Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Moving Average forecasted value of Defence Therapeutics on the next trading day is expected to be 0.50 with a mean absolute deviation of 0.02 and the sum of the absolute errors of 1.17. Defence Therapeutics after-hype prediction price | USD 0.5 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as otc price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Defence |
Defence Therapeutics Additional Predictive Modules
Most predictive techniques to examine Defence price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Defence using various technical indicators. When you analyze Defence charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Defence Therapeutics Simple Moving Average Price Forecast For the 11th of January 2026
Given 90 days horizon, the Simple Moving Average forecasted value of Defence Therapeutics on the next trading day is expected to be 0.50 with a mean absolute deviation of 0.02, mean absolute percentage error of 0.0007, and the sum of the absolute errors of 1.17.Please note that although there have been many attempts to predict Defence OTC Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Defence Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Defence Therapeutics OTC Stock Forecast Pattern
| Backtest Defence Therapeutics | Defence Therapeutics Price Prediction | Buy or Sell Advice |
Defence Therapeutics Forecasted Value
In the context of forecasting Defence Therapeutics' OTC Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Defence Therapeutics' downside and upside margins for the forecasting period are 0.01 and 5.21, respectively. We have considered Defence Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of Defence Therapeutics otc stock data series using in forecasting. Note that when a statistical model is used to represent Defence Therapeutics otc stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 109.0677 |
| Bias | Arithmetic mean of the errors | 8.0E-4 |
| MAD | Mean absolute deviation | 0.0194 |
| MAPE | Mean absolute percentage error | 0.0335 |
| SAE | Sum of the absolute errors | 1.165 |
Predictive Modules for Defence Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Defence Therapeutics. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Other Forecasting Options for Defence Therapeutics
For every potential investor in Defence, whether a beginner or expert, Defence Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Defence OTC Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Defence. Basic forecasting techniques help filter out the noise by identifying Defence Therapeutics' price trends.Defence Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Defence Therapeutics otc stock to make a market-neutral strategy. Peer analysis of Defence Therapeutics could also be used in its relative valuation, which is a method of valuing Defence Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Defence Therapeutics Technical and Predictive Analytics
The otc stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Defence Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Defence Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Defence Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Defence Therapeutics otc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Defence Therapeutics shares will generate the highest return on investment. By undertsting and applying Defence Therapeutics otc stock market strength indicators, traders can identify Defence Therapeutics entry and exit signals to maximize returns.
| Accumulation Distribution | 561.96 | |||
| Daily Balance Of Power | (1.00) | |||
| Rate Of Daily Change | 0.96 | |||
| Day Median Price | 0.5 | |||
| Day Typical Price | 0.5 | |||
| Price Action Indicator | (0.01) | |||
| Period Momentum Indicator | (0.02) |
Defence Therapeutics Risk Indicators
The analysis of Defence Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Defence Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting defence otc stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.26 | |||
| Semi Deviation | 3.36 | |||
| Standard Deviation | 4.73 | |||
| Variance | 22.35 | |||
| Downside Variance | 22.17 | |||
| Semi Variance | 11.26 | |||
| Expected Short fall | (5.93) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Currently Active Assets on Macroaxis
Other Information on Investing in Defence OTC Stock
Defence Therapeutics financial ratios help investors to determine whether Defence OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Defence with respect to the benefits of owning Defence Therapeutics security.